Efficacy of protease inhibitor monotherapyvs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials-Reference-Cited by-同舟云学术

Efficacy of protease inhibitor monotherapyvs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials

Published:2015-12-28 Issue:5 Volume:17 Page:358-367
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Arribas JR¹,Girard P-M²,Paton N³,Winston A⁴,Marcelin A-G⁵,Elbirt D⁶,Hill A⁷,Hadacek MB⁸

Affiliation:

1. IdiPAZ; La Paz Hospital; Madrid Spain

2. Department of Infectious and Tropical Diseases; Saint Antoine Hospital; AP-HP, and INSERM UMR S 1136; Paris France

3. Yong Loo Lin School of Medicine; National University of Singapore; Singapore City Singapore

4. Department of Medicine; Imperial College; London UK

5. Virology; AP-HP, Pitié-Salpêtrière Hospital; INSERM-Sorbonne University; UPMC University of Paris 06, UMR S 1136; Paris France

6. AIDS Centre; Kaplan Medical Centre; Rehovot Israel

7. Pharmacology and Therapeutics; University of Liverpool; Liverpool UK

8. EMEA; Janssen; Issy-les-Moulineux France

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference38 articles.

1. British HIV Association guidelines for the treatment of HIV-1-postivie adults with antiretroviral therapy 2012;BHIVA;HIV Med,2014

2. EACS EACS Treatment Guidelines. Version 7.1 http://www.eacsociety.org/files/guidelines-7.1-english.pdf

3. Panel on Antiretrovial Guidelines for Adults aA Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 2014 Department of Health and Human Services http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pd

4. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis;Mathis;PLoS ONE,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT);eClinicalMedicine;2024-03

2. A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance;Journal of Antimicrobial Chemotherapy;2023-12-28

3. Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus;Medicine;2022-12-09

4. Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial;Clinical Microbiology and Infection;2022-08

5. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial;The Lancet HIV;2022-02